India to test four drugs for Covid-19 as part of the WHO solidarity trial - (The Economic Times via NewsPoints Desk)

  • India will start clinical trials on the effectiveness of four antiviral drugs against COVID-19 as part of the World Health Organization's "Solidarity Trial," reported The Economic Times.

  • The Indian Council of Medical Research announced that potential antiviral agents, including Gilead Sciences' remdesivir, as well as chloroquine/hydroxychloroquine, lopinavir-ritonavir and lopinavir-ritonavir with interferon, will be evaluated as part of the trial.

  • "The required regulatory and ethical approvals have already been obtained and clinical trial sites have started to recruit patients in the trial," said Sheela Godbole, national coordinator for the Solidarity Trial in India.

To read more NewsPoints articles, click here.